Skip to Content

  • Search

View Additional Section Content

A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia Artemisiifolia) Sublingual Immunotherapy Tablet, in Children With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02478398?term=sub+lingual+immunotherapy++tablet+on+ragweed&rank=1

Clinical Trial Categories

  • Allergy
Contact
Ann Schwartz, RN at 877-877-8839

Location

  • Allergy and Asthma Specialists, PC
    470 Sentry Parkway East, Ste 200
    Blue Bell, PA 19422
    Office: 610-825-5800
    Fax: 610-397-0980

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details